Skip to content

rTMS in Facilitation of Working Memory in PD

rTMS in Facilitation of Working Memory in PD

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03059212
Enrollment
60
Registered
2017-02-23
Start date
2017-10-30
Completion date
2021-12-31
Last updated
2021-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson Disease

Keywords

working memory, parkinson's disease, cognition, rTMS

Brief summary

Ten sessions of repetitive transcranial magnetic stimulation yield ability to upregulate the function of primary motor cortex and prefrontal cortex that play key roles in motor and frontal memory processing.

Detailed description

Excitatory (\>3Hz) rTMS could facilitate the brain cortex and neuroplasticity that benefits motor control and working memory when the coil is applied over primary motor cortex or dorsolateral prefrontal cortex.

Interventions

DEVICErTMS

High frequency rTMS for 3 to 10 min to increase the excitability of cortex.

A rehabilitation protocol that facilitates attention, memory, execution.

Sponsors

Taipei Veterans General Hospital, Taiwan
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Intervention model description

Real rTMS, sham rTMS

Eligibility

Sex/Gender
ALL
Age
30 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* Clinical diagnosis of Parkinson's Disease * With symptoms of cognitive impairments, such as memory, attention, or language decline.

Exclusion criteria

* History of seizure attack * Alzheimer's disease * With cardiac pacemaker implantation

Design outcomes

Primary

MeasureTime frameDescription
Change of Repeatable Battery for the Assessment of Neuropsychological Statusup to 12 weeksThis battery measures the cognitive functions including attention, memory, language, visuospatial domains.

Secondary

MeasureTime frameDescription
Change of Montreal Cognitive Assessment ; MoCAup to 12 weeksAssessing cognitive function including delaying recall, attention, executive function, language...

Countries

Taiwan

Contacts

Primary ContactPo-Yi Tsai, MD
vivitsai0518@gmail.com886-22875729

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026